within Pharmacolibrary.Drugs.ATC.G;

model G03XA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.2,
    Cl             = 0.024,
    adminDuration  = 600,
    adminMass      = 0.2,
    adminCount     = 1,
    Vd             = 0.0013,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006500000000000001,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Danazol is a synthetic steroid derived from ethisterone. It has weak androgenic, anabolic, and progestogenic activity and is used clinically for the treatment of endometriosis, hereditary angioedema, and fibrocystic breast disease. It is currently approved and used for select indications, though its use has decreased with the advent of alternative therapies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after a single oral dose in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Pade, D, et al., &amp; Martinez, MN (2019). Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 141 191–209. DOI:<a href=&quot;https://doi.org/10.1016/j.ejpb.2019.05.024&quot;>10.1016/j.ejpb.2019.05.024</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31150808/&quot;>https://pubmed.ncbi.nlm.nih.gov/31150808</a></p></li><li><p>Fukuno, S, et al., &amp; Konishi, H (2023). Danazol increases the oral bioavailability of midazolam by inactivation of hepatic and intestinal CYP3A in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 53(5) 421–428. DOI:<a href=&quot;https://doi.org/10.1080/00498254.2023.2253314&quot;>10.1080/00498254.2023.2253314</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37640546/&quot;>https://pubmed.ncbi.nlm.nih.gov/37640546</a></p></li><li><p>Hooper, WD, et al., &amp; Dickinson, RG (1991). Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans. <i>Biopharmaceutics &amp; drug disposition</i> 12(8) 577–582. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510120804&quot;>10.1002/bdd.2510120804</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1801964/&quot;>https://pubmed.ncbi.nlm.nih.gov/1801964</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end G03XA01;
